Tereshko, Y.; Dal Bello, S.; Pez, S.; Belgrado, E.; Lettieri, C.; Ercole, B.H.; Cellante, G.; Del Regno, C.; Sportelli, G.; Ermanis, G.;
et al. Comparative Study of the Efficacy of Anti-CGRP mAbs on Migraineurs: Analysis of the First Year of Therapy, 1-Month Suspension Period, and Reprisal. J. Clin. Med. 2023, 12, 7329.
https://doi.org/10.3390/jcm12237329
AMA Style
Tereshko Y, Dal Bello S, Pez S, Belgrado E, Lettieri C, Ercole BH, Cellante G, Del Regno C, Sportelli G, Ermanis G,
et al. Comparative Study of the Efficacy of Anti-CGRP mAbs on Migraineurs: Analysis of the First Year of Therapy, 1-Month Suspension Period, and Reprisal. Journal of Clinical Medicine. 2023; 12(23):7329.
https://doi.org/10.3390/jcm12237329
Chicago/Turabian Style
Tereshko, Yan, Simone Dal Bello, Sara Pez, Enrico Belgrado, Christian Lettieri, Bruno Hector Ercole, Giulia Cellante, Caterina Del Regno, Giuseppe Sportelli, Giovanni Ermanis,
and et al. 2023. "Comparative Study of the Efficacy of Anti-CGRP mAbs on Migraineurs: Analysis of the First Year of Therapy, 1-Month Suspension Period, and Reprisal" Journal of Clinical Medicine 12, no. 23: 7329.
https://doi.org/10.3390/jcm12237329
APA Style
Tereshko, Y., Dal Bello, S., Pez, S., Belgrado, E., Lettieri, C., Ercole, B. H., Cellante, G., Del Regno, C., Sportelli, G., Ermanis, G., Versace, S., Merlino, G., Gigli, G. L., & Valente, M.
(2023). Comparative Study of the Efficacy of Anti-CGRP mAbs on Migraineurs: Analysis of the First Year of Therapy, 1-Month Suspension Period, and Reprisal. Journal of Clinical Medicine, 12(23), 7329.
https://doi.org/10.3390/jcm12237329
